BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32014849)

  • 1. Xenogeneic Neu5Gc and self-glycan Neu5Ac epitopes are potential immune targets in MS.
    Boligan KF; Oechtering J; Keller CW; Peschke B; Rieben R; Bovin N; Kappos L; Cummings RD; Kuhle J; von Gunten S; Lünemann JD
    Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 32014849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.
    Hecker M; Fitzner B; Wendt M; Lorenz P; Flechtner K; Steinbeck F; Schröder I; Thiesen HJ; Zettl UK
    Mol Cell Proteomics; 2016 Apr; 15(4):1360-80. PubMed ID: 26831522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk.
    Samraj AN; Bertrand KA; Luben R; Khedri Z; Yu H; Nguyen D; Gregg CJ; Diaz SL; Sawyer S; Chen X; Eliassen H; Padler-Karavani V; Wu K; Khaw KT; Willett W; Varki A
    PLoS One; 2018; 13(6):e0197464. PubMed ID: 29912879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis.
    Van Haren K; Tomooka BH; Kidd BA; Banwell B; Bar-Or A; Chitnis T; Tenembaum SN; Pohl D; Rostasy K; Dale RC; O'Connor KC; Hafler DA; Steinman L; Robinson WH
    Mult Scler; 2013 Nov; 19(13):1726-33. PubMed ID: 23612879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Recognition of Diet-Derived Neu5Gc-Neoantigens on Glycan Microarrays by Carbohydrate-Specific Pooled Human IgG and IgA Antibodies.
    Leviatan Ben-Arye S; Schneider C; Yu H; Bashir S; Chen X; von Gunten S; Padler-Karavani V
    Bioconjug Chem; 2019 May; 30(5):1565-1574. PubMed ID: 30994337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay.
    Leviatan Ben-Arye S; Yu H; Chen X; Padler-Karavani V
    J Vis Exp; 2017 Jul; (125):. PubMed ID: 28745644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of immunogenic Neu5Gc in bioprosthetic heart valves.
    Reuven EM; Leviatan Ben-Arye S; Marshanski T; Breimer ME; Yu H; Fellah-Hebia I; Roussel JC; Costa C; Galiñanes M; Mañez R; Le Tourneau T; Soulillou JP; Cozzi E; Chen X; Padler-Karavani V
    Xenotransplantation; 2016 Sep; 23(5):381-92. PubMed ID: 27610947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.
    Castellazzi M; Contini C; Tamborino C; Fasolo F; Roversi G; Seraceni S; Rizzo R; Baldi E; Tola MR; Bellini T; Granieri E; Fainardi E
    J Neuroinflammation; 2014 Nov; 11():188. PubMed ID: 25391491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody profiling in multiple sclerosis reveals novel antigenic candidates.
    Somers V; Govarts C; Somers K; Hupperts R; Medaer R; Stinissen P
    J Immunol; 2008 Mar; 180(6):3957-63. PubMed ID: 18322204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.
    Padler-Karavani V; Hurtado-Ziola N; Pu M; Yu H; Huang S; Muthana S; Chokhawala HA; Cao H; Secrest P; Friedmann-Morvinski D; Singer O; Ghaderi D; Verma IM; Liu YT; Messer K; Chen X; Varki A; Schwab R
    Cancer Res; 2011 May; 71(9):3352-63. PubMed ID: 21505105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing-remitting multiple sclerosis.
    Beyer NH; Lueking A; Kowald A; Frederiksen JL; Heegaard NH
    J Neuroimmunol; 2012 Jan; 242(1-2):26-32. PubMed ID: 22177943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit.
    Silber E; Semra YK; Gregson NA; Sharief MK
    Neurology; 2002 May; 58(9):1372-81. PubMed ID: 12011283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid.
    Taylor RE; Gregg CJ; Padler-Karavani V; Ghaderi D; Yu H; Huang S; Sorensen RU; Chen X; Inostroza J; Nizet V; Varki A
    J Exp Med; 2010 Aug; 207(8):1637-46. PubMed ID: 20624889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of Neu5Gc and Presence of Anti-Neu5Gc Antibodies in Humans-An Evolutionary Perspective.
    Altman MO; Gagneux P
    Front Immunol; 2019; 10():789. PubMed ID: 31134048
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Perota A; Galli C
    Front Immunol; 2019; 10():2396. PubMed ID: 31681287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis.
    Schwarz M; Spector L; Gortler M; Weisshaus O; Glass-Marmor L; Karni A; Dotan N; Miller A
    J Neurol Sci; 2006 May; 244(1-2):59-68. PubMed ID: 16480743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of N-glycolylneuraminic acid and Galα1-3Galβ1-4GlcNAc epitopes in xenogeneic cells attenuates cytotoxicity of human natural antibodies.
    Basnet NB; Ide K; Tahara H; Tanaka Y; Ohdan H
    Xenotransplantation; 2010; 17(6):440-8. PubMed ID: 21158945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients.
    Jaśkiewicz E; Michałowska-Wender G; Pyszczek A; Wender M
    Folia Neuropathol; 2010; 48(1):45-8. PubMed ID: 20383810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human antibody reactivity against xenogeneic N-glycolylneuraminic acid and galactose-α-1,3-galactose antigen.
    Hurh S; Kang B; Choi I; Cho B; Lee EM; Kim H; Kim YJ; Chung YS; Jeong JC; Hwang JI; Kim JY; Lee BC; Surh CD; Yang J; Ahn C
    Xenotransplantation; 2016 Jul; 23(4):279-92. PubMed ID: 27373998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are there specific antibodies against Neu5Gc epitopes in the blood of healthy individuals?
    Obukhova P; Tsygankova S; Chinarev A; Shilova N; Nokel A; Kosma P; Bovin N
    Glycobiology; 2020 May; 30(6):395-406. PubMed ID: 31897477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.